PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
20.29%
Revenue growth under 50% of CVE's 166.83%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
15.01%
Gross profit growth under 50% of CVE's 654.58%. Michael Burry would be concerned about a severe competitive disadvantage.
132.99%
EBIT growth below 50% of CVE's 325.67%. Michael Burry would suspect deeper competitive or cost structure issues.
132.99%
Operating income growth under 50% of CVE's 325.67%. Michael Burry would be concerned about deeper cost or sales issues.
150.33%
Net income growth at 50-75% of CVE's 243.79%. Martin Whitman would question fundamental disadvantages in expenses or demand.
150.21%
EPS growth at 75-90% of CVE's 176.92%. Bill Ackman would push for improved profitability or share repurchases to catch up.
149.15%
Diluted EPS growth at 75-90% of CVE's 183.33%. Bill Ackman would expect further improvements in net income or share count reduction.
0.40%
Share reduction more than 1.5x CVE's 71.41%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
2.39%
Diluted share reduction more than 1.5x CVE's 65.57%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.40%
Dividend reduction while CVE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
15.02%
Positive OCF growth while CVE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
26.86%
FCF growth of 26.86% while CVE is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-37.58%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
58.08%
5Y revenue/share CAGR at 75-90% of CVE's 73.67%. Bill Ackman would encourage strategies to match competitor’s pace.
4.57%
3Y revenue/share CAGR under 50% of CVE's 23.34%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-26.03%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
241.13%
Positive OCF/share growth while CVE is negative. John Neff might see a comparative advantage in operational cash viability.
62.15%
3Y OCF/share CAGR under 50% of CVE's 212.91%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
124.29%
Net income/share CAGR above 1.5x CVE's 74.76% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
152.80%
5Y net income/share CAGR at 75-90% of CVE's 177.01%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
52.87%
Below 50% of CVE's 120.49%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-86.16%
Negative equity/share CAGR over 10 years while CVE stands at 6.05%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-51.37%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-54.42%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-90.76%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
19.56%
Stable or rising mid-term dividends while CVE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
19.52%
Our short-term dividend growth is positive while CVE cut theirs. John Neff views it as a comparative advantage in shareholder returns.
40.60%
AR growth is negative/stable vs. CVE's 151.80%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
No Data
No Data available this quarter, please select a different quarter.
0.45%
Asset growth well under 50% of CVE's 61.83%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
7.31%
Positive BV/share change while CVE is negative. John Neff sees a clear edge over a competitor losing equity.
-6.78%
We’re deleveraging while CVE stands at 86.55%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
318.18%
SG&A growth well above CVE's 8.67%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.